SlideShare a Scribd company logo
1 of 16
Transplantation Of Immunity
SlideMake.com
1
Introduction
Transplantation of immunity refers to the
transfer of immune cells or antibodies from
one individual to another to enhance
immune responses.
This approach can be used to treat various
diseases, including cancer, autoimmune
disorders, and infectious diseases.
The goal of transplantation of immunity is
to boost the recipient's immune system and
provide protection against specific
pathogens or antigens.
2
Types of Immune Transplantation
Passive immunity transfer involves the
direct transfer of pre-formed antibodies or
immune cells from a donor to a recipient.
Active immunity transfer involves
stimulating the recipient's immune system
to produce its antibodies or immune cells in
response to a specific antigen.
Combination approaches may include both
passive and active immunity transfer to
achieve a synergistic effect.
3
Sources of Immune Cells
Immune cells for transplantation can be
sourced from blood donations, bone
marrow, cord blood, or specific immune cell
populations.
Donor selection is crucial to ensure
compatibility and minimize the risk of
rejection or adverse reactions.
Advances in technology have enabled the
isolation and expansion of specific immune
cell populations for targeted therapies.
4
Applications of Immune Cell Transplantation
Adoptive cell therapy involves the infusion
of ex vivo expanded immune cells, such as
T cells or natural killer cells, to target and
eliminate cancer cells.
Stem cell transplantation can be used to
replenish the immune system in patients
with hematologic malignancies or genetic
immune deficiencies.
Immune cell therapy can also be tailored to
target autoimmune diseases by modulating
immune responses and promoting
tolerance.
5
Challenges in Immune Cell Transplantation
Immune cell rejection can occur if the
recipient's immune system recognizes the
transplanted cells as foreign and mounts an
immune response.
Graft-versus-host disease (GVHD) is a
potential complication of immune cell
transplantation, where donor immune cells
attack the recipient's tissues.
Balancing the desired immune response
with the risk of adverse effects is a key
challenge in immune cell transplantation.
6
Engineering Immune Cells
Genetic engineering techniques, such as
CAR-T cell therapy, allow for the
modification of immune cells to enhance
their targeting capabilities.
Chimeric antigen receptors (CARs) can be
designed to recognize specific tumor
antigens and trigger immune cell activation
and killing.
Engineered immune cells offer the potential
for precise and personalized
immunotherapy approaches in the
treatment of cancer and other diseases.
7
Immunomodulatory Therapies
Immune checkpoint inhibitors are a type of
immunomodulatory therapy that enhances
the immune response against cancer cells
by blocking inhibitory pathways.
Cytokine therapy involves the
administration of immune-modulating
proteins to regulate immune responses and
promote anti-tumor activity.
Targeted immunomodulatory therapies aim
to modulate specific immune cell
populations or pathways to enhance overall
immune function.
8
Clinical Outcomes and Success Stories
Immune cell transplantation has shown
promising results in the treatment of
hematologic malignancies, with high
response rates and durable remissions.
CAR-T cell therapy has demonstrated
remarkable efficacy in certain types of
leukemia and lymphoma, leading to FDA
approvals for specific indications.
Long-term follow-up studies are essential to
assess the safety, durability, and potential
for immune cell transplantation to become
a standard of care in various diseases.
9
Future Directions in Immune Cell Transplantation
Personalized medicine approaches, such
as tumor-specific immune cell therapies,
are being developed to tailor treatments to
individual patients.
Combination therapies that integrate
immune cell transplantation with other
modalities, such as chemotherapy or
radiation therapy, are being explored to
enhance treatment outcomes.
Advances in understanding immune cell
biology and immunotherapy mechanisms
will drive the development of novel immune
cell transplantation strategies in the future.
10
Regulatory Considerations
Regulatory agencies play a critical role in
overseeing the development and approval
of immune cell transplantation therapies to
ensure safety and efficacy.
Manufacturing standards for immune cell
products must meet rigorous quality control
criteria to ensure consistency and
reproducibility.
Collaboration between industry, academia,
and regulatory bodies is essential for
advancing immune cell transplantation as a
mainstream therapeutic approach.
11
Ethical and Social Implications
Ethical considerations surrounding immune
cell transplantation include issues related to
donor consent, patient autonomy, and
equitable access to novel therapies.
Social factors, such as cost, insurance
coverage, and healthcare disparities, can
impact the accessibility and affordability of
immune cell transplantation for patients.
Education and public awareness
campaigns are needed to inform
stakeholders about the benefits, risks, and
implications of immune cell transplantation
in healthcare.
12
Key Takeaways
Transplantation of immunity involves the
transfer of immune cells or antibodies to
enhance immune responses in recipients.
Different types of immune cell
transplantation, sources, applications,
challenges, and future directions are
shaping the field of immunotherapy.
Regulatory, ethical, and social
considerations play a vital role in the
development, implementation, and
acceptance of immune cell transplantation
as a therapeutic modality.
13
References
Insert relevant citations, research studies,
and resources that support the content
presented in the slides.
Acknowledge the contributions of
researchers, clinicians, and organizations
in advancing the field of immune cell
transplantation.
Include any relevant regulatory guidelines
or policies that govern immune cell
transplantation practices and standards.
14
Questions and Discussion
Encourage audience participation by
inviting questions, comments, or
discussions on the topic of immune cell
transplantation.
Facilitate a dialogue on the potential
impact, challenges, and opportunities
associated with immune cell transplantation
in healthcare.
Engage attendees in critical thinking and
reflection on the implications of immune cell
transplantation for future research and
clinical practice.
15
Thank You
Express gratitude to the audience for their
attention, engagement, and interest in the
presentation on transplantation of immunity.
Provide contact information for further
inquiries, collaborations, or follow-up
discussions on immune cell transplantation
topics.
Conclude the presentation with a positive
note and encourage continued exploration
and learning in the field of immunotherapy.

More Related Content

Similar to Transplantation Of Immunity immune system.pptx

Novel_technologies_and _emerging_biomarkers_for_personalized_cancer_immunothe...
Novel_technologies_and _emerging_biomarkers_for_personalized_cancer_immunothe...Novel_technologies_and _emerging_biomarkers_for_personalized_cancer_immunothe...
Novel_technologies_and _emerging_biomarkers_for_personalized_cancer_immunothe...
TOKBLS
 
Antimicrobial Stewardship ,Heba Abdallatif,BCPS
Antimicrobial Stewardship  ,Heba Abdallatif,BCPSAntimicrobial Stewardship  ,Heba Abdallatif,BCPS
Antimicrobial Stewardship ,Heba Abdallatif,BCPS
Heba Abd Allatif
 
Brayer j.-l.-et-al.-2015-acute-myeloid-leukemia-and-myelodysplastic-syndrome
Brayer j.-l.-et-al.-2015-acute-myeloid-leukemia-and-myelodysplastic-syndromeBrayer j.-l.-et-al.-2015-acute-myeloid-leukemia-and-myelodysplastic-syndrome
Brayer j.-l.-et-al.-2015-acute-myeloid-leukemia-and-myelodysplastic-syndrome
SellasCorp
 
iOncologi_Pitch Deck_2024 slide show for hostinger
iOncologi_Pitch Deck_2024 slide show for hostingeriOncologi_Pitch Deck_2024 slide show for hostinger
iOncologi_Pitch Deck_2024 slide show for hostinger
ssuser9354ce
 
2005 Plague and anthrax JI Ania
2005 Plague and anthrax JI Ania2005 Plague and anthrax JI Ania
2005 Plague and anthrax JI Ania
Ania Skowera, PhD
 
The Immunotherapy in Cancer Treatment Occurring Advancement in Using the Immu...
The Immunotherapy in Cancer Treatment Occurring Advancement in Using the Immu...The Immunotherapy in Cancer Treatment Occurring Advancement in Using the Immu...
The Immunotherapy in Cancer Treatment Occurring Advancement in Using the Immu...
ijtsrd
 

Similar to Transplantation Of Immunity immune system.pptx (20)

Novel_technologies_and _emerging_biomarkers_for_personalized_cancer_immunothe...
Novel_technologies_and _emerging_biomarkers_for_personalized_cancer_immunothe...Novel_technologies_and _emerging_biomarkers_for_personalized_cancer_immunothe...
Novel_technologies_and _emerging_biomarkers_for_personalized_cancer_immunothe...
 
Crosstalk Between Cancer Inflammation and Immunity: Host Defense Webinar Seri...
Crosstalk Between Cancer Inflammation and Immunity: Host Defense Webinar Seri...Crosstalk Between Cancer Inflammation and Immunity: Host Defense Webinar Seri...
Crosstalk Between Cancer Inflammation and Immunity: Host Defense Webinar Seri...
 
Vaccinomics
VaccinomicsVaccinomics
Vaccinomics
 
cellular and molecular pharmacology - presentation
cellular and molecular pharmacology - presentationcellular and molecular pharmacology - presentation
cellular and molecular pharmacology - presentation
 
presentation for miss sana .pdf
presentation for miss sana .pdfpresentation for miss sana .pdf
presentation for miss sana .pdf
 
Antimicrobial Stewardship ,Heba Abdallatif,BCPS
Antimicrobial Stewardship  ,Heba Abdallatif,BCPSAntimicrobial Stewardship  ,Heba Abdallatif,BCPS
Antimicrobial Stewardship ,Heba Abdallatif,BCPS
 
Cancer vaccines 20_july2020
Cancer vaccines 20_july2020Cancer vaccines 20_july2020
Cancer vaccines 20_july2020
 
Brayer j.-l.-et-al.-2015-acute-myeloid-leukemia-and-myelodysplastic-syndrome
Brayer j.-l.-et-al.-2015-acute-myeloid-leukemia-and-myelodysplastic-syndromeBrayer j.-l.-et-al.-2015-acute-myeloid-leukemia-and-myelodysplastic-syndrome
Brayer j.-l.-et-al.-2015-acute-myeloid-leukemia-and-myelodysplastic-syndrome
 
iOncologi_Pitch Deck_2024 slide show for hostinger
iOncologi_Pitch Deck_2024 slide show for hostingeriOncologi_Pitch Deck_2024 slide show for hostinger
iOncologi_Pitch Deck_2024 slide show for hostinger
 
2005 Plague and anthrax JI Ania
2005 Plague and anthrax JI Ania2005 Plague and anthrax JI Ania
2005 Plague and anthrax JI Ania
 
Immunotherapy the Present and Future of Cancer Treatment
Immunotherapy the Present and Future of Cancer TreatmentImmunotherapy the Present and Future of Cancer Treatment
Immunotherapy the Present and Future of Cancer Treatment
 
Clinical trials and safety considerations
Clinical trials and safety considerationsClinical trials and safety considerations
Clinical trials and safety considerations
 
Know about Cell Therapy from The Point of Standardization, Scale, and Industr...
Know about Cell Therapy from The Point of Standardization, Scale, and Industr...Know about Cell Therapy from The Point of Standardization, Scale, and Industr...
Know about Cell Therapy from The Point of Standardization, Scale, and Industr...
 
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
 
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
 
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
 
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
 
Peruzzi2015
Peruzzi2015Peruzzi2015
Peruzzi2015
 
The Immunotherapy in Cancer Treatment Occurring Advancement in Using the Immu...
The Immunotherapy in Cancer Treatment Occurring Advancement in Using the Immu...The Immunotherapy in Cancer Treatment Occurring Advancement in Using the Immu...
The Immunotherapy in Cancer Treatment Occurring Advancement in Using the Immu...
 
Tumour Immunology
Tumour ImmunologyTumour Immunology
Tumour Immunology
 

Recently uploaded

Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
palsonia139
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
MedicoseAcademics
 

Recently uploaded (20)

Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw5cladba raw material 5CL-ADB-A precursor raw
5cladba raw material 5CL-ADB-A precursor raw
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
Sonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptxSonia Journal club presentation (2).pptx
Sonia Journal club presentation (2).pptx
 
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptxIs Rheumatoid Arthritis a Metabolic Disorder.pptx
Is Rheumatoid Arthritis a Metabolic Disorder.pptx
 
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)Cervical screening – taking care of your health flipchart (Vietnamese)
Cervical screening – taking care of your health flipchart (Vietnamese)
 
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.GawadHemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
Hemodialysis: Chapter 1, Physiological Principles of Hemodialysis - Dr.Gawad
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
HyperIgE syndrome: primary immune deficiency.pdf
HyperIgE syndrome: primary immune deficiency.pdfHyperIgE syndrome: primary immune deficiency.pdf
HyperIgE syndrome: primary immune deficiency.pdf
 
Evidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapyEvidence-based practiceEBP) in physiotherapy
Evidence-based practiceEBP) in physiotherapy
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
DR. Neha Mehta Best Psychologist.in India
DR. Neha Mehta Best Psychologist.in IndiaDR. Neha Mehta Best Psychologist.in India
DR. Neha Mehta Best Psychologist.in India
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
Mgr university bsc nursing adult health previous question paper with answers
Mgr university  bsc nursing adult health previous question paper with answersMgr university  bsc nursing adult health previous question paper with answers
Mgr university bsc nursing adult health previous question paper with answers
 
Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.Muscle Energy Technique (MET) with variant and techniques.
Muscle Energy Technique (MET) with variant and techniques.
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 

Transplantation Of Immunity immune system.pptx

  • 2. 1 Introduction Transplantation of immunity refers to the transfer of immune cells or antibodies from one individual to another to enhance immune responses. This approach can be used to treat various diseases, including cancer, autoimmune disorders, and infectious diseases. The goal of transplantation of immunity is to boost the recipient's immune system and provide protection against specific pathogens or antigens.
  • 3. 2 Types of Immune Transplantation Passive immunity transfer involves the direct transfer of pre-formed antibodies or immune cells from a donor to a recipient. Active immunity transfer involves stimulating the recipient's immune system to produce its antibodies or immune cells in response to a specific antigen. Combination approaches may include both passive and active immunity transfer to achieve a synergistic effect.
  • 4. 3 Sources of Immune Cells Immune cells for transplantation can be sourced from blood donations, bone marrow, cord blood, or specific immune cell populations. Donor selection is crucial to ensure compatibility and minimize the risk of rejection or adverse reactions. Advances in technology have enabled the isolation and expansion of specific immune cell populations for targeted therapies.
  • 5. 4 Applications of Immune Cell Transplantation Adoptive cell therapy involves the infusion of ex vivo expanded immune cells, such as T cells or natural killer cells, to target and eliminate cancer cells. Stem cell transplantation can be used to replenish the immune system in patients with hematologic malignancies or genetic immune deficiencies. Immune cell therapy can also be tailored to target autoimmune diseases by modulating immune responses and promoting tolerance.
  • 6. 5 Challenges in Immune Cell Transplantation Immune cell rejection can occur if the recipient's immune system recognizes the transplanted cells as foreign and mounts an immune response. Graft-versus-host disease (GVHD) is a potential complication of immune cell transplantation, where donor immune cells attack the recipient's tissues. Balancing the desired immune response with the risk of adverse effects is a key challenge in immune cell transplantation.
  • 7. 6 Engineering Immune Cells Genetic engineering techniques, such as CAR-T cell therapy, allow for the modification of immune cells to enhance their targeting capabilities. Chimeric antigen receptors (CARs) can be designed to recognize specific tumor antigens and trigger immune cell activation and killing. Engineered immune cells offer the potential for precise and personalized immunotherapy approaches in the treatment of cancer and other diseases.
  • 8. 7 Immunomodulatory Therapies Immune checkpoint inhibitors are a type of immunomodulatory therapy that enhances the immune response against cancer cells by blocking inhibitory pathways. Cytokine therapy involves the administration of immune-modulating proteins to regulate immune responses and promote anti-tumor activity. Targeted immunomodulatory therapies aim to modulate specific immune cell populations or pathways to enhance overall immune function.
  • 9. 8 Clinical Outcomes and Success Stories Immune cell transplantation has shown promising results in the treatment of hematologic malignancies, with high response rates and durable remissions. CAR-T cell therapy has demonstrated remarkable efficacy in certain types of leukemia and lymphoma, leading to FDA approvals for specific indications. Long-term follow-up studies are essential to assess the safety, durability, and potential for immune cell transplantation to become a standard of care in various diseases.
  • 10. 9 Future Directions in Immune Cell Transplantation Personalized medicine approaches, such as tumor-specific immune cell therapies, are being developed to tailor treatments to individual patients. Combination therapies that integrate immune cell transplantation with other modalities, such as chemotherapy or radiation therapy, are being explored to enhance treatment outcomes. Advances in understanding immune cell biology and immunotherapy mechanisms will drive the development of novel immune cell transplantation strategies in the future.
  • 11. 10 Regulatory Considerations Regulatory agencies play a critical role in overseeing the development and approval of immune cell transplantation therapies to ensure safety and efficacy. Manufacturing standards for immune cell products must meet rigorous quality control criteria to ensure consistency and reproducibility. Collaboration between industry, academia, and regulatory bodies is essential for advancing immune cell transplantation as a mainstream therapeutic approach.
  • 12. 11 Ethical and Social Implications Ethical considerations surrounding immune cell transplantation include issues related to donor consent, patient autonomy, and equitable access to novel therapies. Social factors, such as cost, insurance coverage, and healthcare disparities, can impact the accessibility and affordability of immune cell transplantation for patients. Education and public awareness campaigns are needed to inform stakeholders about the benefits, risks, and implications of immune cell transplantation in healthcare.
  • 13. 12 Key Takeaways Transplantation of immunity involves the transfer of immune cells or antibodies to enhance immune responses in recipients. Different types of immune cell transplantation, sources, applications, challenges, and future directions are shaping the field of immunotherapy. Regulatory, ethical, and social considerations play a vital role in the development, implementation, and acceptance of immune cell transplantation as a therapeutic modality.
  • 14. 13 References Insert relevant citations, research studies, and resources that support the content presented in the slides. Acknowledge the contributions of researchers, clinicians, and organizations in advancing the field of immune cell transplantation. Include any relevant regulatory guidelines or policies that govern immune cell transplantation practices and standards.
  • 15. 14 Questions and Discussion Encourage audience participation by inviting questions, comments, or discussions on the topic of immune cell transplantation. Facilitate a dialogue on the potential impact, challenges, and opportunities associated with immune cell transplantation in healthcare. Engage attendees in critical thinking and reflection on the implications of immune cell transplantation for future research and clinical practice.
  • 16. 15 Thank You Express gratitude to the audience for their attention, engagement, and interest in the presentation on transplantation of immunity. Provide contact information for further inquiries, collaborations, or follow-up discussions on immune cell transplantation topics. Conclude the presentation with a positive note and encourage continued exploration and learning in the field of immunotherapy.

Editor's Notes

  1. Image source: https://ar.inspiredpencil.com/pictures-2023/antibody-mediated-immunity
  2. Image source: https://ar.inspiredpencil.com/pictures-2023/types-of-immunity
  3. Image source: https://lymphoma-action.org.uk/about-lymphoma-treatment-lymphoma/stem-cell-transplants
  4. Image source: https://www.the-scientist.com/infographics/infographic-how-immunotherapy-could-boost-stem-like-t-cells-67711
  5. Image source: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(20)30404-X/fulltext?rss=yes
  6. Image source: https://axel-kblankenship.blogspot.com/2022/04/car-t-cell-production-protocol.html
  7. Image source: https://www.frontiersin.org/articles/10.3389/fimmu.2022.1045957/full
  8. Image source: https://www.slidemake.com
  9. Image source: https://www.slidemake.com
  10. Image source: https://www.go1.com/lo/regulatory-compliance/24595663/
  11. Image source: https://www.slidemake.com
  12. Image source: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.631365/full
  13. Image source: https://www.museumlegs.com/research-paper/012-mla-format-research-paper-what-is-forn-essay-examples-sample-citation-example-customer-service-resume-citing/
  14. Image source: https://www.fearlesspresentations.com/9-reliable-ways-to-add-audience-participation-to-your-presentation/
  15. Image source: https://medium.com/@awatifhy/the-power-of-giving-thanks-15-ways-to-express-gratitude-69c13e7f9613